Skip to Content

391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint 391 G is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 391 G

Carbidopa and Levodopa Extended Release

391 G
50 mg / 200 mg
Elliptical / Oval
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Global Pharmaceuticals
Inactive Ingredients:
hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.